Cite
Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease.
MLA
Grandi, Norma Christine, et al. “Serum Parathyroid Hormone and Risk of Adverse Outcomes in Patients with Stable Coronary Heart Disease.” Heart, vol. 97, no. 15, Aug. 2011, pp. 1215–21. EBSCOhost, https://doi.org/10.1136/hrt.2011.223529.
APA
Grandi, N. C., Breitling, L. P., Hahmann, H., Wüsten, B., Miärz, W., Rothenbacher, D., & Brenner, H. (2011). Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease. Heart, 97(15), 1215–1221. https://doi.org/10.1136/hrt.2011.223529
Chicago
Grandi, Norma Christine, Lutz Philipp Breitling, Harry Hahmann, Bernd Wüsten, Winfred Miärz, Dietrich Rothenbacher, and Hermann Brenner. 2011. “Serum Parathyroid Hormone and Risk of Adverse Outcomes in Patients with Stable Coronary Heart Disease.” Heart 97 (15): 1215–21. doi:10.1136/hrt.2011.223529.